Cabaluna, Leanna M.

HRN: 06-03-28  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2022
CEFUROXIME 750MG (VIAL)
04/24/2022
04/30/2022
IVT
750mg
Q8
Prophylaxis For S/P Episiorraphy

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Guideline Not Available